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Human osteoarthrit ic cartilage exhibits the 2B6 epitope without 
pretreatment with chondroit inase ABC 
Introduction/Summary 
THE MONOCLONAL ANTIBODY, 2B6, recognizes the 
chondroitin-4-sulfate (C4S) stub of proteoglycans 
resulting from chondroitinase ABC digestion [1]. 
Demonstration of C4S in normal control cartilage 
by immunohistochemistry using 2B6 requires 
pre-treatment by digestion via chondroitinase 
ABC. However, we found that osteoarthritic (OA) 
fibrillated cartilage reacted with 2B6 without 
enzymatic pre-digestion. The spontaneous immuno- 
reactivity to 2B6 in OA cartilage was observed 
mainly intracellularly in superficial chondrocytes. 
To examine the possibility that this staining of C4S 
could have resulted from degradation i lysosomes, 
its co-localization with cathepsin B (CB) or D (CO), 
used as representative lysosomal proteinases [2-4], 
was analyzed by double immunostaining using 
confocal aser scanning microscopy. Inununoreac- 
tivity to CB and CD was not demonstrated in the 
chondrocyte granules immunostained by 2B6. 
Using double staining with 2B6 and propidium 
iodide, a nuclear marker, positive staining of 2B6 
appeared both in the nucleus and cytoplasmic 
granules of chondrocytes. The results suggest that 
a native form of C4S recognized by 2B6 exists in the 
OA chondrocytes, both in the cytoplasmic granules 
and nuclei of the cells. 
Methods/Results/Discussion 
Human OA cartilage was studied by immuno- 
histochemistry for the detection of the C4S epitope 
recognized by the monoclononal antibody 2B6 
(Seikagaku Corporation, Tokyo, Japan). The carti- 
lage samples were obtained from the femoral 
condyles of the knee joints in 10 OA patients (two 
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men and eight women aged 71 __ 8 years and having 
a disease duration of 8.8 _+ 4 years) at the time of 
total knee-joint replacement. No patient received 
any medication for 2 weeks before surgery. 
Macroscopically normal cartilage samples ob- 
tained from these joints were used as controls. 
Histologically the control specimens showed 
neither fissuring nor changes in alcian blue 
staining. 
The samples were fixed with 95% ethanol/5% 
acetic acid for 24h and decalcified with 10% 
EDTA-2Na, pH 7.0, for 1 month. They were then 
embedded in paraffin and cut into 5 #m thick 
sections. Rabbit antibodies to rat Cathepsin B (CB) 
and C~thepsin C (CO) were purified by affinity 
chromatography, as reported previously [3, 4]. For 
single immunostaining, deparaffinized sections 
were incubated with 2B6 (1:100) followed by 
fluorescein-isothiocynate-conjugated (FITC) anti- 
mouse IgG (Jackson Lab., PA, U.S.A.). For double 
immunostaining, the 2B6 stained sections were 
treated for 1 h at room temperature with anti-CB 
(1i/~g/ml) or anti-CO (27/~g/ml) followed by Cy5 
conjugated anti-rabbit IgG (Jackson Lab., PA, 
U.S.A.). Some sections used for the immunostaining 
were pre-treated with 5 unit/ml of chondroitinase 
ABC (Seikagaku Corporation, Tokyo, Japan) in 
100 mM sodium acetate buffer, pH 8.0, at 37°C for 
1 h. Sections immunostained with Cy5 or FITC- 
conjugated secondary antibodies were viewed with 
a eonfocal laser scanning microscope (TCS 4D, 
Leica). 
Control cartilage specimens showed no im- 
munoreactivity to 2B6 when pre-treatment by 
chondroitinase ABC was not performed [Fig. l(a)]. 
After pre-treatment with chondroitinase ABC, 
~mmunoreactivity to 2B6 was observed in the 
chondrocytes and pericellular matrix of the 
superficial and deep cartilage zones [Fig. l(b)]. This 
agrees with our previous results indicating that 
concentration of chondroitin sulfate is highest in 
the deep zone of human articular cartilage [5]. 
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However, the absence of immunostaining in the 
middle cartilage zone remains unclear. 
In OA cartilage samples that showed cartilage 
fibrillation and cell clusters, in tense  immuno- 
reactivity to 2B6 was demonstrated without 
Chondroitinase ABC pre-treatment. The staining 
was mainly seen in clustered cells of the super- 
ficial zone, although weak immunoreactivity was 
seen in the extracellular matrix [Fig. 2(a)]. 
Pre-treatment with chondroitinase ABC enhanced 
the immunostaining of 2B6 in the pericellular 
matrix of the superficial zone, and generated it in 
the chondrocytes and extracellular matrix of the 
deep cartilage zone [Fig. 2(b)]. The pre-treatment 
with chondroitinase ABC slightly reduced or did 
not change the immunoreactivity to 2B6 of the 
clustered cells. The immunoreactivity in the 
extracellular matrix of all zones was enhanced 
by the pre-treatment with chondroitinase ABC 
[Fig. 2(b)]. 
Proteoglycans of the extracellular matrix are 
degraded in situ by proteinases uch as metallo- 
proteinases, which are active at neutral pH [6]. 
However, it is possible that lysosomal enzymes 
could have a secondary role in the digestion 
of proteoglycan after fragments previously 
degraded in the matrix are ingested by cells [6]. It 
is also conceivable that newly synthesized C4S 
could be trapped by, and degraded in, lysosomes 
during vesicular transport from the Golgi complex 
to the cell membrane before secretion. Therefore, 
we examined the co-localization of the native 
epitope of 2B6 with lysosomal CB and CD. 
Immunoreactivity o CD was seen in the cells of 
some fibrillated samples but was highly variable 
[Fig. 2(c) and 2(d)]. However, co-localization of the 
native 2B6 epitope and CD was never observed in 
the chondrocytes of fibrillated samples [Fig. 2(c) 
and 2(e)]. Immunostainability for CB was weak, but 
it showed the same localization as CD (data not 
shown). 
Cartilage samples were double stained with 
2B6 and propidium iodide solution (10ttg/ml 
propidium iodide; Sigma, 100mM NaC1, 10mM 
Tris-C1; pH 7.4, l mM EDTA and 10mM 2- 
mercaptoethylamine hydrochloride) to further 
examine the intracellular localization of C4S. The 
immunostaining of 2B6 appeared in the cytoplasm 
and also in the nuclei of clustered cells [Fig. 2(f)]. 
Both nuclear and cytoplasmic immunostaining 
of 2B6 were observed in the cells of three cases, 
but the other seven cases showed only cyto- 
plasmic immunostaining of 2B6. The nuclear 
localization of various glycosaminoglycans has 
been demonstrated by many biochemical studies 
[7]. Su et al. have shown that heparan sulfate 
(HS) could be immunostained in the nuclei of 
brain neurons from patients who have 
Alzheimer's disease, but not in the healthy 
neurons, which are immunopositive for HS in the 
cytoplasm only [8]. The finding suggests that 
abnormal transport of glycosaminoglycans from the 
cytoplasm into the nucleus occurs in Alzheimer 
neurons. It remains unknown whether the intra- 
cellular immunostaining of 2B6 in clustered cells 
is localized in certain organelles or in the 
ground cytoplasm. The nuclear localization of 2B6 
jmmunostaining in OA chondrocytes suggests that 
a native form of C4S, recognized by 2B6, could be 
generated in the cytoplasm and transported into 
the nucleus. 
Immunodeposits of 2B6 were occasionally found 
at the surface of clustered cells in the OA cartilage 
superficial zone [Fig. 2(f)]. However, the immuno- 
deposits of 2B6 were faint or not observed in 
the intercellular matrix. The integration of 
proteoglycans containing the native 2B6 epitope 
into the extracellular matrix might, be greatly 
reduced in OA cartilage, in relation with an 
accelerated turn-over and a decreased ability to 
interact with hyaluronic acid [9, 10]. 
We could not find co-localization of the 
native 2B6 epitope and cathepsins, suggesting that 
the native epitope of 2B6 is not present in the 
lysosome. However, it remains unclear as to 
whether the native 2B6 epitope is generated by 
enzymes that degrade chondroitin sulfate at 
neutral pH, such as neutral hyaluronidase or 
endo-fl-glucuronidase [11]. Moreover, Ishihara 
et al. have shown that a rat hepatocyte cell 
line, without lysosomal processing, takes up 
proteoheparan sulfate and transports the internal- 
ized heparan sulfate into the nucleus where it 
appeared as free chains in a unique structure 
which is enriched in sulfated glucronic acid [12]. 
This suggests that glycosaminoglycans in the 
nucleus and their processing have unique styles, 
and that unknown chondroitinase-like enzymes, 
that generate unsaturated saccharides of 
glycosaminoglycans at neutral pH exist in the OA 
cartilage. 
Because the native epitope of 3B3 that recognizes 
a native chondroitin-6-sulfate structure greatly 
increases in articular cartilage and synovial fluids 
of OA patients, it has been suggested that the native 
epitope of 3B3 could be a specific marker of ongoing 
anabolic events in early OA [13-15]. Further studies 
are required to determine whether the native 
epitope of 2B6 is generated in anabolic or catabolic 
events. 
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FIG. 1. Control cartilage immunostained by 2B6- and FITC-conjugated anti-mouse IgG. No immunoreactivity to 2B6 
is seen without chondroitinase ABC pre-treatment (a). Immunoreactivity to 2B6 (arrows) is seen in chondrocytes and 
pericellular matrix of superficial and deep cartilage zones after chondroitinase ABC pre-treatment (b). 
Magnification × 119. 
FIG. 2. Fibrillated OA cartilage immunostained by 2B6- and FITC-conjugated anti-mouse IgG. (a) No chondroitinase 
pre-treatment: spontaneous immunoreactivity to 2B6 in superficial clustered cells (arrows). (b) After chondroitinase 
ABC digestion: increased immunoreactivity o 2B6 in pericellular matrix of the superficial zone (arrowheads), 
generation of immunoreactivity to 2B6 in cells and matrix of the deep zone (arrows). Magnification x 80. (c) Double 
immunostaining with cathepsin D (CD) antibodies and Cy5-conjugated anti-rabbit IgG. Immunoreactivity to CD (blue) 
is shown by deep cells (thick arrows) whereas immunoreactivity to 2B6 (green) is demonstrated by superficial cells 
(short arrows). Magnification ×125. (d) Co-localization of C4S and CD i snot  observed in superficial cells 
immunopositive for both C4S and CD. (e) Intense immunoreactivity for CD, contrasting with the absence of 2B6 
immunoreactivity in deep cartilage cells. Magnification x 1425. (f) Double staining with propidium iodide (Nomarsky 
differential interference contrast microscopy), hnmunoreactivity o 2B6 is shown in cytoplasm (arrowheads), nuclei 
(thick arrows) and cell surface (short arl:ows). Yellow indicates staining with both 2B6 and propidium iodide. 
Magnification × 2850. 
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